// App-Quantinova.ai

POS02 : Comparative efficacy and safety of anticoagulation strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients

Researchers

Presenter

  • Schulze V

Principal Investigators

  • Kowalewski M

  • Kolodziejczak M

  • Lip G.Y

  • Kelm M

  • Navarese E.P

Medical Centers

  • Heinrich-Heine-Universitat, Dusseldorf, Germany

  • Nicolaus Copernicus Hospital, Bydgoszcz, Poland

  • Univ of Birmingham Cntr for Cardiovascular Sciences, Birmingham, United Kingdom

Locations

  • Poland

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Heparin

  • Fondaparinux sodium

  • Bivalirudin

  • Otamixaban

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved